|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-4-6
|
|
pubmed:abstractText |
Imatinib slows development of chronic myeloid leukemia (CML). However, available information on morbidity and mortality is largely based on sponsored trials, whereas independent long-term field studies are lacking.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1460-2105
|
|
pubmed:author |
pubmed-author:AbruzzeseElisabettaE,
pubmed-author:AntoliniLauraL,
pubmed-author:AssoulineSaritS,
pubmed-author:D'EmilioAnnaA,
pubmed-author:DeiningerMichaelM,
pubmed-author:Della CasaChiara MariaCM,
pubmed-author:DurosinmiMuheez AMA,
pubmed-author:FavaCarmenC,
pubmed-author:Gambacorti-PasseriniCarloC,
pubmed-author:GiraldoPilarP,
pubmed-author:GuilhotFrancoisF,
pubmed-author:Hurtado-MonroyRafaelR,
pubmed-author:JangEunjungE,
pubmed-author:KimDong-WookDW,
pubmed-author:LeeksmaOnnoO,
pubmed-author:MahonFrançois-XavierFX,
pubmed-author:MartinoBrunoB,
pubmed-author:MorraEnricaE,
pubmed-author:NaglerArnonA,
pubmed-author:PaneFabrizioF,
pubmed-author:PiccinAndreaA,
pubmed-author:PoglianiEnrico MariaEM,
pubmed-author:PuttiniMiriamM,
pubmed-author:ReiffersJosyJ,
pubmed-author:SantiniValeriaV,
pubmed-author:StagnoFabioF,
pubmed-author:ValsecchiMaria GraziaMG,
pubmed-author:le CoutrePhilippP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
6
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
553-61
|
|
pubmed:meshHeading |
pubmed-meshheading:21422402-Adult,
pubmed-meshheading:21422402-Aged,
pubmed-meshheading:21422402-Antineoplastic Agents,
pubmed-meshheading:21422402-Drug Administration Schedule,
pubmed-meshheading:21422402-Female,
pubmed-meshheading:21422402-Follow-Up Studies,
pubmed-meshheading:21422402-Humans,
pubmed-meshheading:21422402-Kaplan-Meier Estimate,
pubmed-meshheading:21422402-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:21422402-Male,
pubmed-meshheading:21422402-Middle Aged,
pubmed-meshheading:21422402-Odds Ratio,
pubmed-meshheading:21422402-Piperazines,
pubmed-meshheading:21422402-Polymerase Chain Reaction,
pubmed-meshheading:21422402-Protein Kinase Inhibitors,
pubmed-meshheading:21422402-Pyrimidines,
pubmed-meshheading:21422402-Remission Induction,
pubmed-meshheading:21422402-Time Factors,
pubmed-meshheading:21422402-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.
|
|
pubmed:affiliation |
Hematology and Clinical Research Unit, San Gerardo Hospital, Italy. carlo.gambacorti@unimib.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
